Vital Farms (VITL)
(Delayed Data from NSDQ)
$35.73 USD
+1.40 (4.08%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $35.73 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$35.73 USD
+1.40 (4.08%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $35.73 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum A VGM
Zacks News
Energizer (ENR) Gains From Project Momentum & Debt Reduction
by Zacks Equity Research
Energizer (ENR) is well-positioned for long-term success and shareholder value, with a focus on consumer engagement, market expansion, innovation and effective debt reduction.
Helen of Troy's (HELE) Stock Down More Than 57% YTD: Here's Why
by Zacks Equity Research
Helen of Troy (HELE) is facing a tough operational environment, heightened macroeconomic uncertainty and a financially-strained consumer environment.
Kellanova (K) Stock Jumps 10% in a Week: What's the Buzz About?
by Zacks Equity Research
Kellanova's (K) stock surge follows Mars' plan to acquire the company. The deal aligns well for both companies, with Kellanova set to gain from Mars' global reach and resources.
Here's Why Sprouts Farmers (SFM) Has Rallied 25% in 3 Months
by Zacks Equity Research
Sprouts Farmers (SFM) is expanding its customer base through product innovation and targeted marketing.
Molson Coors' (TAP) Revitalization Plan & Innovation Aid
by Zacks Equity Research
Molson Coors (TAP) enjoys the benefits from its revitalization plan, product portfolio and expansion in growth areas.
Vital Farms (VITL) Loses -28.17% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Vital Farms (VITL) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Medifast (MED) Tumbles 25% in 3 Months: Should You Buy Now?
by Zacks Equity Research
Medifast (MED) is encountering difficulties in attracting customers due to a reduction in the number of active OPTAVIA Coaches and diminished productivity per Coach.
General Mills (GIS) Hurt by Volatile Consumer Trends, Cost Woes
by Zacks Equity Research
While brand strength and the Accelerate strategy aid General Mills (GIS), the challenging operating environment and cost-related hurdles keep the near term under pressure.
Vital Farms and J. B. Hunt have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Vital Farms and J. B. Hunt are part of the Zacks Bull and Bear of the Day article.
Bull Of The Day: Vital Farms (VITL)
by Brian Bolan
This stock traded lower following its 6th consecutive beat of the Zacks Consensus Estimate and it might be a great opportunity to buy the dip.
Is Vital Farms (VITL) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Vital Farms (VITL) could produce exceptional returns because of its solid growth attributes.
Newell (NWL) Stock Declines 22% in 3 Months: Can it Rebound?
by Zacks Equity Research
Newell (NWL) is battling uncertainties like a tough macroeconomic environment and elevated levels of core inflation, leading to soft discretionary demand and soft sales
Lamb Weston (LW) Down More Than 40% in 6 Months: Here's Why
by Zacks Equity Research
Lamb Weston (LW) is battling key issues like ongoing input cost inflation, persistent execution difficulties and a softening in global demand for frozen fries.
McCormick's (MKC) Solid Brands & Cost Savings Propel Growth
by Zacks Equity Research
McCormick's (MKC) commitment to achieving long-term objectives is evident from its proven track record and wide-reaching and competitive global portfolio with a focus on high-growth areas.
Conagra Brands (CAG) Fuels Portfolio With Sweetwood Smoke Buyout
by Zacks Equity Research
Conagra Brands' (CAG) acquisition of Sweetwood Smoke & Co. highlights its focus on expanding in the innovative, high-protein snacks category.
Best Momentum Stocks to Buy for August 12th
by Zacks Equity Research
VITL, APP and HRTG made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 12, 2024.
Are Consumer Staples Stocks Lagging British American Tobacco (BTI) This Year?
by Zacks Equity Research
Here is how British American Tobacco (BTI) and Vital Farms (VITL) have performed compared to their sector so far this year.
Nu Skin (NUS) Trims FY24 View Despite Q2 Earnings Beat
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2024 results reflect lower earnings and net sales amid a dynamic macro-environment. Management lowers the 2024 guidance range.
Monster Beverage (MNST) Stock Down on Q2 Earnings & Sales Miss
by Zacks Equity Research
Monster Beverage (MNST) posts soft second-quarter 2024 results. Its Monster Energy Drinks segment's sales rise 3.3% year over year.
Wall Street Analysts See Vital Farms (VITL) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Vital Farms (VITL). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Vital Farms (VITL) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of 71.43% and 2.53%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Inter Parfums (IPAR) Q2 Earnings Top, Sales Up on Robust Demand
by Zacks Equity Research
Inter Parfums' (IPAR) second-quarter 2024 results reflect higher sales and earnings on continued momentum in the fragrance market and strength in its legacy and new brands.
Sally Beauty (SBH) Q3 Earnings in the Cards: Things to Note
by Zacks Equity Research
Sally Beauty's (SBH) third-quarter fiscal 2024 performance will likely reflect the adverse impact of a decline in customer traffic and inflationary pressures.
Grocery Outlet's (GO) Q2 Earnings Beat, Comps Jump 2.9% Y/Y
by Zacks Equity Research
Grocery Outlet's (GO) second-quarter results reflect a comparable store sales increase of 2.9%. Management anticipates comparable store sales growth of 3.5% for 2024.
B&G Foods (BGS) Q2 Earnings Meet Estimates, Unit Volumes Dip
by Zacks Equity Research
B&G Foods' (BGS) second-quarter 2024 results reflect lower earnings and sales amid demand challenges in the consumer-packaged food space.